Tarsus Pharmaceuticals Inc. (TARS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tarsus Pharmaceuticals In...

    NASDAQ: TARS · Real-Time Price · USD
    55.39
    0.13 (0.24%)
    At close: Sep 25, 2025, 3:59 PM

    Tarsus Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 182.95M 17.45M 25.82M 57.03M
    Cost of Revenue
    		 12.83M 1.59M 955K 2.08M
    Gross Profit
    		 170.13M 15.85M 24.86M 54.95M
    Operating Income
    		 -120.57M -143.16M -62.71M -12.16M
    Interest Income
    		 15.01M 10.34M 3.5M 36K
    Pretax Income
    		 -115.55M -135.89M -62.09M -13.77M
    Net Income
    		 -115.55M -135.89M -62.09M -13.83M
    Selling & General & Admin
    		 237.31M 108.7M 44.95M 25.4M
    Research & Development
    		 53.39M 50.31M 42.62M 41.71M
    Other Expenses
    		 n/a n/a 86K -73K
    Operating Expenses
    		 290.7M 159.01M 87.57M 67.11M
    Interest Expense
    		 7.85M 3.35M 2.2M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 303.52M 160.6M 88.53M 69.18M
    Income Tax Expense
    		 n/a n/a -4K 55K
    Shares Outstanding (Basic)
    		 37.6M 29.38M 24.62M 20.55M
    Shares Outstanding (Diluted)
    		 37.6M 29.38M 24.62M 20.55M
    EPS (Basic)
    		 -3.07 -4.62 -2.52 -0.67
    EPS (Diluted)
    		 -3.07 -4.62 -2.52 -0.67
    EBITDA
    		 -106.48M -131.67M -59.11M -13.17M
    EBIT
    		 -108.11M -132.67M -59.9M -13.77M
    Depreciation & Amortization
    		 1.23M 877K 789K 606K

    Add to Watchlist